China’s Insatiable Appetite For Latest Therapies Prompts Ex-Exec To Take New Journey
Neukio Sees NK Promise
Executive Summary
After immuno-oncology, cell therapies such as CAR-Ts have attracted millions of dollars of funding in China and one former executive is now sailing into the largely uncharted waters of natural killer cells.